Dr Miguel Camara, MD in Crest Hill, IL - Allergy & Immunology

Dr Miguel Camara, MD is a Allergy & Immunology - Allergy physician based in Crest Hill, Illinois. Dr Miguel Camara is licensed to practice in Illinois (license number 036092279) and his current practice location is 2228 Weber Rd, Crest Hill, Illinois. He can be reached at his office (for appointments etc.) via phone at (815) 729-9900.

NPI number for Dr Miguel Camara is 1447369327 and his current mailing address is 2228 Weber Rd, Crest Hill, Illinois. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1447369327.

Contact Information

	Dr Miguel Camara, MD
	2228 Weber Rd, Crest Hill, IL 60403-0928
	(815) 729-9900
	(815) 729-9913

Physician's Profile

Full Name	Dr Miguel Camara
Gender	Male
Speciality	Allergy & Immunology - Allergy
Location	2228 Weber Rd, Crest Hill, Illinois
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1447369327
Provider Enumeration Date: 08/30/2006
Last Update Date: 01/26/2017

Medical Identifiers

Medical identifiers for Dr Miguel Camara such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1447369327	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207KA0200X	Allergy & Immunology - Allergy	036092279 (Illinois)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Miguel Camara is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Miguel Camara, MD 2228 Weber Rd, Crest Hill, IL 60403-0928 Ph: (815) 729-9900	Dr Miguel Camara, MD 2228 Weber Rd, Crest Hill, IL 60403-0928 Ph: (815) 729-9900

News Archive

Researchers use clever screening methods to speed vaccine production

Infectious diseases-both old and new-continue to exact a devastating toll, causing some 13 million fatalities per year around the world. Vaccines remain the best line of defense against deadly pathogens and now Kathryn Sykes and Stephen Johnston, researchers at Arizona State University's Biodesign Institute, along with co-author Michael McGuire from the University of Texas Southwestern Medical Center are using clever functional screening methods to attempt to speed new vaccines into production that are both safer and more potent.

Florida: Confusion surrounds cost of Medicaid expansions included in reform proposals

Health News Florida reports on a flap over how much the proposed expansion of Medicaid included in some health reform proposals would cost the state of Florida. The news service examined a story published in the Orlando Sentinel and the South Florida Sun-Sentinel.

America's Got Talent Donald Braswell to participate in "Songs for Sara" Benefit Concert

Donald Braswell, 4th place winner from TV's "America's Got Talent" 2008 season, and William Stokking, retired principal cellist of the Philadelphia Orchestra, are featured in the "Songs for Sara" Benefit Concert for Sara Ann Kronrot, a six-year-old Collingswood girl with profound cerebral palsy.

TGen collaborates with Samuel Oschin Comprehensive Cancer Institute for clinical trials

Cedars-Sinai has combined efforts with the Translational Genomics Research Institute (TGen) in Arizona so researchers may offer joint clinical trials and collaborate to develop personalized therapies that could lead to more effective cancer treatments.

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Novartis has announced that Gleevec (imatinib mesylate) tablets, (known as Glivec (imatinib) outside the US, Canada and Israel), has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).

Dr Miguel Camara, MD - Allergy & Immunology in Crest Hill, IL